Open Label Dose Escalation Trial of AB-205 (E-CEL® cells) in Adults with Lymphoma Undergoing High-Dose Therapy and Autologous Hematopoietic Cell Transplantation (HDT-AHCT)
March 16, 2021 Abstract: HDT-AHCT is a standard curative [...]
Results of an Open Label Dose Escalation Trial of AB-205 (E-CEL® cells) in Adults with Lymphoma Undergoing High-Dose Therapy and Autologous Hematopoietic Cell Transplantation (HDT-AHCT)
Abstract: HDT-AHCT is a standard potentially curative therapy for [...]
Results of a Phase 1 Open Label Dose Escalation Trial of AB-205 (Allogeneic Engineered Endothelial Cell Therapy) in Adults with Lymphoma Undergoing High-Dose Therapy and Autologous Hematopoietic Cell Transplantation (HDT-AHCT)
Abstract: HDT-AHCT is a standard and potentially curative therapy [...]
Endothelial transplantation rejuvenates aged hematopoietic stem cell function
Abstract: Age-related changes in the hematopoietic compartment are primarily attributed [...]